Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LowNO: Budesonide in Suspected Asthma with Low Exhaled NO
NCT02771717Phase 4Unknown
- Sponsor
- University of Nottingham
- Start
- May 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Budesonide with Placebo (2 arms). Primary endpoint: Asthma Control Questionnaire at 12 weeks. Status: unknown.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02771717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02771717.